Trademark: 79272215
Word
SYNPLOGEN
Status
Registered
Status Code
700
Status Date
Tuesday, August 4, 2020
Serial Number
79272215
Registration Number
6115549
Registration Date
Tuesday, August 4, 2020
Mark Type
4000
Filing Date
Thursday, August 22, 2019
Published for Opposition
Tuesday, May 19, 2020

Trademark Owner History
Synplogen Co., Ltd. - Original Registrant

Classifications
42 Research and development relating to DNA synthesis technology; technical advisory services and * providing * information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; * providing * technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; * providing * technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; * providing * information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; [ DNA sequence design services for scientific research purposes; ] research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research
In the Statement, class 42 has been updated per the Restriction, and per the fnote dated April 20, 2022.

Trademark Events
Feb 17, 2023
Invalidation Reviewed - No Action Required By Office
Dec 24, 2022
Partial Invalidation Of Reg Ext Protection Created
Jul 30, 2022
New Representative At Ib Received
Apr 25, 2022
Limitation From The Ib Examined And Entered
Apr 24, 2022
Correction Under Section 7 ¿ Processed
Feb 5, 2022
Limitation Of Goods Received From Ib
Dec 12, 2020
Final Decision Transaction Processed By Ib
Nov 25, 2020
Final Disposition Notice Sent To Ib
Nov 25, 2020
Final Disposition Processed
Nov 4, 2020
Final Disposition Notice Created, To Be Sent To Ib
Aug 4, 2020
Registered-Principal Register
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 13, 2020
Approved For Pub - Principal Register
Mar 23, 2020
Teas/Email Correspondence Entered
Mar 23, 2020
Correspondence Received In Law Office
Mar 19, 2020
Assigned To Lie
Mar 12, 2020
Teas Response To Office Action Received
Jan 31, 2020
Notification Of Non-Final Action E-Mailed
Jan 31, 2020
Non-Final Action E-Mailed
Jan 31, 2020
Non-Final Action Written
Jan 17, 2020
Refusal Processed By Ib
Jan 14, 2020
Teas/Email Correspondence Entered
Jan 14, 2020
Correspondence Received In Law Office
Jan 14, 2020
Teas Response To Office Action Received
Jan 2, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Jan 2, 2020
Refusal Processed By Mpu
Dec 4, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Dec 3, 2019
Non-Final Action Written
Nov 26, 2019
Application Filing Receipt Mailed
Nov 22, 2019
Assigned To Examiner
Nov 22, 2019
New Application Office Supplied Data Entered
Nov 21, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24